FindMyKOL

Subhashis Banerjee, MD

Enriched profile

Senior Scientist · University of Virginia

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Princeton, NJ · Northeast · United StatesSpecialtyInternal MedicineFocusPsoriasis: Treatment and Pathogenesis+4
Active KOLFindMyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2023–2025NIH fundingNone on fileWhy? →

Subhashis Banerjee is Senior Scientist at University of Virginia. OpenAlex indexes 265 publications with 9,709 citations (h-index 38); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Internal Medicine profiles in the FindMyKOL directory.

Data verified 13 Nov 2026

Overview

Updated 14 Nov 2026

Subhashis Banerjee, MD, is Senior Scientist at University of Virginia. The public record shows 265 publications with 9,709 citations (h-index 38), centered on Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Dermatology and Skin Diseases. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 2 companies.

  • Most recent indexed publication: 2026 · bioRxiv
  • Top research focus: Psoriasis: Treatment and Pathogenesis
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hodgkin Disease1 trialLymphoma1 trialALSAlzheimer's / DementiaAtopic Dermatitis / EczemaCOVID-19HIVIBD (Crohn's / UC)Lupus (SLE)Multiple SclerosisOsteoarthritisPsoriasis (Derm)Psoriasis / Psoriatic ArthritisRheumatoid ArthritisAnkylosing Spondylitis / SpA

Research focus

OpenAlex concept fingerprint
Psoriasis: Treatment and PathogenesisSpondyloarthritis Studies and TreatmentsDermatology and Skin DiseasesRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research

Drugs & molecules

across trials, industry payments and publications
Adbrygeneric · TralokinumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Artiva Biotherapeutics, Inc.Clinical trials1Industry payments—LEO Pharma Inc.Clinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
265publications

Publications indexed by OpenAlex, matched via ORCID. 5 in PubMed. Counts exclude supporting files.

9,709citations

Citations across these publications.

38h-index

H-index from these publications. i10-index 74.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Nov 2026

2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 13 Nov 2026

49 congress contributions (2012–2026) across AAD, ASTCT, ECCO Congress, EULAR, SID per OpenAlex. The most recent:

Publications

Updated 13 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 13 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/subhashis-banerjee-2b4945162

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.